Archived: VIDEO: Taking Medicine Personally—Addressing Emerging Patient Needs


Christi Shaw

U.S. Country Head,

President of Novartis Corporation and

President of Novartis Pharmaceuticals Corporation

Christi was appointed U.S. Country Head, President of Novartis Corporation & President of Novartis Pharmaceuticals Corporation in April 2014. She joined Novartis in July 2010 as Head of North America Novartis Oncology where she oversaw all operations including Medical, Commercial and staff functions for U.S. and Canada. During her tenure there, the North America Oncology business achieved unprecedented positive growth despite key patent losses. She improved margins while successfully launching two new chemical entities (NCEs) and six new indications. This contributed to strong strategic brands growth.

Christi brings more than 25 years of pharmaceutical and medical device experience with strong strategic capabilities in commercial, financial, clinical development, medical affairs, and operations leadership in uniquely challenging situations. She has worked across many different therapeutic areas including cardiovascular, CNS, oncology, infectious disease, rare diseases and Women’s Health. Her continued dedication to ensuring patient access to innovative medicines, along with her ability to mobilize organizations to deliver results that exceed expectations, are hallmarks of her leadership.

Prior to Novartis, Christi was Vice President, New Business Development & Strategic Analytics for Ethicon, a Johnson & Johnson company. There she was responsible for strategy and pipeline, developing new and adjacent product categories which led to two significant acquisitions, and the company’s business information and analytics capabilities. Before that role, Christi was Vice President, Worldwide Marketing, Ethicon Products, where she worked with R&D to accelerate the pipeline, resulting in six product launches in 3 years.

Christi joined Johnson & Johnson in 2002 at Janssen Pharmaceuticals. During her tenure in there, she rose through a number of key positions with increasing responsibility within Janssen Psychiatry, Ortho Women’s Health & Urology and McNeil Pediatrics. She joined the device and diagnostic division at Ethicon in 2007.

Christi started her career in pharmaceuticals at Eli Lilly and Company where she worked for 14 years, successfully laying the foundation of her experience in sales and management. She has an MBA from the University of Wisconsin and a BA from Iowa State University.

Latest News

Southern Company Builds on Transparency of Corporate Responsibility and Sustainability Efforts

Originally published at southerncompany.mediaroom.com. Southern Company ranked No. 19 on The DiversityInc Top 50 Companies for Diversity list in 2022.   Consistent with its commitment to transparency and stakeholder engagement, Southern Company has published its 2021 Corporate Responsibility Executive Summary, refreshed key environmental, social and governance (ESG) data and published…

A Sysco truck with a branded message makes it way through traffic.

Sysco Shares Its First Diversity, Equity and Inclusion Report

Originally published at investors.sysco.com.    Sysco Corporation, the leading global foodservice distribution company, announced the launch of its 2022 Sustainability Report and the company’s first Diversity, Equity and Inclusion (DEI) Report. “Sustainability is an integral part of our business strategy, called the Recipe For Growth, to ensure we are growing responsibly and…

Toyota Recognizes Everyday Heroes at the espnW Summit

Originally published at pressroom.toyota.com. Toyota Motor North America ranked No. 4 on The DiversityInc Top 50 Companies for Diversity list in 2022.    The espnW: Women + Sports Summit in Ojai, California, presented by Toyota, Toyota and espnW announced the seventh class of Toyota Everyday Heroes. Toyota’s Everyday Heroes program…